Despite recent share price drops, Gansu Longshenrongfa Pharm...
Despite recent share price drops, Gansu Longshenrongfa Pharmaceutical's P/E is still higher than most firms. If medium-term earnings trends persist, shareholders' investments could be at risk and potential investors may pay an excessive premium.
![](https://pubimg-10000538.picsh.myqcloud.com/202205090000015700007535a2c.jpg)
Disclaimer: The above information does not represent the views of Moomoo Technologies Inc. (MTI) or constitute investment advice related to MTI and its affiliates.
Read more
Comment
Sign in to post a comment